Palisade Bio, Inc. (PALI)
NASDAQ·Healthcare·Biotechnology
$1.80
+0.84%
Mkt Cap $293.35M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$1.50
Range $1.50 – $1.50
Implied Upside
-16.7%
Consensus $1.50 vs current $1.80
NASDAQ·Healthcare·Biotechnology
$1.80
+0.84%
Mkt Cap $293.35M
No recent rating data.
Price Target (1 analysts)
$1.50
Range $1.50 – $1.50
-16.7%
Consensus $1.50 vs current $1.80